BrandUnited States

Gilead Sciences Inc. (Kite Pharma)

Gilead Sciences, through its Kite Pharma subsidiary, commands the largest share of the global CAR-T cell therapy market with approximately $1.8 billion in 2025 CGT product sales. While Gilead's overall revenue reached $29.4 billion, its cell therapy portfolio represents an increasingly important growth driver. Kite's manufacturing leadership and deep clinical expertise in lymphoma have established

United StatesScore 70

Core Business Areas

- HIV and antiviral therapeutics - CAR-T cell therapy products through Kite Pharma - Liver disease NASH and oncology small molecules - COVID-19 antiviral remdesivir Veklury

Corporate Report

Core Business

Gilead Sciences is a global biopharmaceutical company with dominant positions in HIV, antiviral, and cell therapy markets. Through its Kite Pharma subsidiary, Gilead has become the world's leading CAR-T cell therapy company, with products treating multiple hematologic malignancies.

Global Presence

Headquartered in Foster City, California, Gilead operates in over 35 countries with 18,000+ employees. Kite's dedicated cell therapy manufacturing campus spans three US sites (California, Maryland) and one European site (Netherlands).

Key Strengths

Gilead's combination of substantial pharmaceutical revenue, Kite's market-leading CAR-T portfolio, and its world-class internal manufacturing network create a formidable position in the CGT landscape. The parent company's financial strength supports continued investment in next-generation cell therapy technologies.

VerityRank Score

70/ 100

Based on market presence, financial scale, operational capacity, and brand strength.

Quick Facts

Headquarters

United States

Visit Website

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website

Back to Rankings